September 28 | 2021
Specialized diagnostic solutions leader Werfen, to distribute 2cureX products in Spain
Read more
August 26 | 2021
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2021
Read more
August 26 | 2021
2cureX publishes interim report for the second quarter and first half of 2021
Read more
May 27 | 2021
2cureX offentliggör delårsrapport för det första kvartalet 2021
Read more
May 27 | 2021
2cureX publishes interim report for the first quarter of 2021
Read more
May 11 | 2021
Teckningsoptioner av serie TO1 tecknades till cirka 96,75 procent och 2cureX AB tillförs cirka 31,40 MSEK
Read more
March 1 | 2021
2cureX announces that the clinical trial of IndiTreat®-guided treatment of metastatic colorectal cancer has met the primary endpoint.
Read more
February 25 | 2021
2cureX publishes year-end report for 2020.
Read more
February 25 | 2021
2cureX offentliggör bokslutskommuniké för räkenskapsåret 2020.
Read more
February 4 | 2021
IndiTreat® selected to prestigious multinational ovarian cancer project.
Read more
January 28 | 2021
2cureX appoints Kenneth Graabek Johansen, an experienced business and financial executive, as new CFO.
Read more
January 5 | 2021
2cureX appoints Fernando Andreu, an international Biotech executive, as new CEO
Read more
October 1 | 2020
Den sista patienten är registrerad med framgång i världens första interventionsstudie med 3D-mikrotumörer som vägledning för val av cancerbehandling.
Read more
October 1 | 2020
Last patient successfully enrolled in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment.
Read more
July 6 | 2020
2cureX har genomfört en riktad nyemission om cirka 40 MSEK som blev kraftigt övertecknad
Read more
July 6 | 2020
2cureX AB avser att genomföra en riktad nyemission av units
Read more
June 25 | 2020
2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program
Read more
June 25 | 2020
2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program
Read more